Rhode Island SB 2203: AN ACT RELATING TO INSURANCE (Requires coverage for the treatment of pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections/pediatric acute onset neuropsychiatric syndrome, including, but not limited to, the use of intravenous immunoglobin therapy.)

Status: 06/30/2022 Signed by Governor (as of 2022-06-30)

State: Rhode Island · Session: 2022 · Bill: SB 2203

Sponsors: Burke, Cano, DiMario, Lawson, Murray, Quezada, Valverde

View Rhode Island SB 2203 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.